Quince Therapeutics Inc (QNCX)
1.06
+0.03
(+2.91%)
USD |
NASDAQ |
Apr 26, 16:00
1.06
0.00 (0.00%)
After-Hours: 20:00
Quince Therapeutics Price to Book Value: 0.5384 for April 26, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| April 26, 2024 | 0.5384 |
| April 25, 2024 | 0.5232 |
| April 24, 2024 | 0.5384 |
| April 23, 2024 | 0.5638 |
| April 22, 2024 | 0.5384 |
| April 19, 2024 | 0.5333 |
| April 18, 2024 | 0.5384 |
| April 17, 2024 | 0.5079 |
| April 16, 2024 | 0.5061 |
| April 15, 2024 | 0.5105 |
| April 12, 2024 | 0.4789 |
| April 11, 2024 | 0.5079 |
| April 10, 2024 | 0.5028 |
| April 09, 2024 | 0.5435 |
| April 08, 2024 | 0.5282 |
| April 05, 2024 | 0.5206 |
| April 04, 2024 | 0.5282 |
| April 03, 2024 | 0.5333 |
| April 02, 2024 | 0.5333 |
| April 01, 2024 | 0.5536 |
| March 28, 2024 | 0.5384 |
| March 27, 2024 | 0.5739 |
| March 26, 2024 | 0.5739 |
| March 25, 2024 | 0.6095 |
| March 22, 2024 | 0.6061 |
| Date | Value |
|---|---|
| March 21, 2024 | 0.5909 |
| March 20, 2024 | 0.5808 |
| March 19, 2024 | 0.6111 |
| March 18, 2024 | 0.601 |
| March 15, 2024 | 0.5859 |
| March 14, 2024 | 0.5859 |
| March 13, 2024 | 0.596 |
| March 12, 2024 | 0.6061 |
| March 11, 2024 | 0.5909 |
| March 08, 2024 | 0.5884 |
| March 07, 2024 | 0.5859 |
| March 06, 2024 | 0.5909 |
| March 05, 2024 | 0.6111 |
| March 04, 2024 | 0.5909 |
| March 01, 2024 | 0.6465 |
| February 29, 2024 | 0.6566 |
| February 28, 2024 | 0.6768 |
| February 27, 2024 | 0.6667 |
| February 26, 2024 | 0.6515 |
| February 23, 2024 | 0.6717 |
| February 22, 2024 | 0.6566 |
| February 21, 2024 | 0.6768 |
| February 20, 2024 | 0.6818 |
| February 16, 2024 | 0.6465 |
| February 15, 2024 | 0.6566 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
0.1958
Minimum
Dec 28 2022
25.12
Maximum
Aug 10 2021
4.595
Average
3.081
Median
Jan 05 2022
Price to Book Value Benchmarks
| NovaBay Pharmaceuticals Inc | 1.739 |
| Palatin Technologies Inc | -- |
| iBio Inc | 0.6668 |
| Theriva Biologics Inc | 0.1946 |
| Oragenics Inc | 2.929 |
Price to Book Value Related Metrics
| Price | 1.06 |
| Earnings Yield | -79.25% |
| Market Cap | 45.81M |